JWH-148

From WikiMD's Medical Encyclopedia

JWH-148.png

JWH-148 is a synthetic cannabinoid from the naphthoylindole family. It acts as a potent agonist for the cannabinoid receptors, specifically the CB1 receptor and CB2 receptor.

Chemical Structure and Properties[edit]

JWH-148 is chemically classified as a naphthoylindole. Its full chemical name is 1-Pentyl-3-(1-naphthoyl)indole. The compound has a molecular formula of C24H23NO and a molecular weight of 341.45 g/mol.

Pharmacology[edit]

JWH-148 functions as a potent agonist for the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system. These receptors are involved in various physiological processes including pain sensation, mood, and memory. The binding affinity of JWH-148 to these receptors is high, making it a significant compound for research in cannabinoid receptor activity.

Legal Status[edit]

The legal status of JWH-148 varies by country. In many jurisdictions, it is classified as a controlled substance due to its psychoactive properties and potential for abuse. It is often included in legislation aimed at regulating synthetic cannabinoids.

Research and Applications[edit]

JWH-148 has been used in scientific research to study the endocannabinoid system and the effects of cannabinoid receptor activation. It has also been utilized in the development of new therapeutic agents targeting these receptors.

Safety and Toxicity[edit]

The safety profile and toxicity of JWH-148 are not well-documented. As with other synthetic cannabinoids, there may be risks associated with its use, including potential for abuse and adverse health effects.

See Also[edit]

References[edit]

External Links[edit]



Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.